News


Nature Biotechnology 25, 365 - 366 (2007)
Published online: 3 April 2007 | doi:10.1038/nbt0407-365

Pharma consolidates its grip on post-antibody landscape

Cormac Sheridan1

  1. Dublin


The next wave of protein therapeutics, based on non-traditional scaffolds, may offer advantages in the range of conditions they can treat, delivery, and manufacturing. But they are just beginning to prove themselves in the clinic.

Top



Extra navigation

Search PubMed for

Open Innovation Challenges

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

  • Fast Growth of Transformed Soybean Shoots

    • Deadline: Jul 15 2009
    • Reward: $10,000 USD

    A method for accelerating growth of soybean shoots is desired.

naturejobs

natureproducts


ADVERTISEMENT